The invention relates to 8-[3-amino-piperidin-1-yl]-xanthines and the physiologically acceptable salts thereof, particularly the hydrochlorides thereof.

Edits on 20 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 20 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Peter Sieger0

Waldemar Pfrengle0

Edits on 14 Jul, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 14 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals US Patent 8106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

Infobox

Patent Number

08106060

Patent Number

8106060

Edits on 14 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 14 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

Infobox

Is a

Patent

Current assignee

Boehringer Ingelheim

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08106060

Date of patent

January 31, 2012

Patent application number

11460996

Date Filed

July 30, 2006

Patent primary examiner

‌

Mark Berch

Find more entities like US Patent 8106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API